193 filings
Page 5 of 10
8-K
t7y7ota xsy5o1u
3 May 19
Departure of Directors or Certain Officers
4:30pm
8-K
xprj1rt45 3acr
15 Apr 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
ecnbh p6sl031d37w6
1 Apr 19
NovaBay Pharmaceuticals Announces Investments of $5 Million to Support U.S. Avenova Commercialization Strategy
9:17am
8-K
q3pme jnyad
28 Mar 19
Entry into a Material Definitive Agreement
8:45am
8-K
cbj6r6me y6
12 Mar 19
NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy
4:30pm
8-K
w3facd
11 Mar 19
Departure of Directors or Certain Officers
4:30pm
8-K
55nxpr0rf9s4qhpj b2u
1 Mar 19
Entry into a Material Definitive Agreement
12:00am
8-K
yc2k xli5x2v7mg0
11 Oct 18
Departure of Directors or Certain Officers
4:30pm
8-K
mi3 1oz8ega
28 Sep 18
NovaBay Pharmaceuticals Names Jack McGovern Interim CEO
4:30pm
8-K
5mjz 16mi9x9bfy3xrc
4 Jun 18
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
te9pi
26 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
klrggoz0rh 1id
23 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
w8kpl7
12 Feb 18
NovaBay Pharmaceuticals Completes $6.0 Million Private Placement
12:00am
8-K
lo9nwz9ef46
6 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
e1hhdb
6 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
9zknaj8m 25sqc
22 Dec 17
NovaBay Pharmaceuticals Receives Stockholder Approval for Proposed $10.32 Million Financing Agreement
12:00am
8-K
zxaeh3i86lswl6 8iul9
20 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
ppjnw8w2k
12 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
lnpsy2o8 5c4fq
28 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
1lughd43 c59
21 Nov 17
Entry into a Material Definitive Agreement
12:00am